A clinical comparison of testosterone enanthate injections versus AndroGel (testosterone gel 1%) covering serum testosterone levels, symptom relief, pharmacokinetics, safety profiles, and patient selection criteria.
A head-to-head comparison of testosterone enanthate injections and Jatenzo (oral testosterone undecanoate) covering cost, insurance access, clinical efficacy, and practical considerations for TRT patients.
A clinical comparison of injectable testosterone enanthate and oral Jatenzo (testosterone undecanoate) covering efficacy, serum testosterone levels, trial data, and practical differences for men on TRT.
A clinical comparison of injectable testosterone enanthate and oral Jatenzo (testosterone undecanoate), including pharmacokinetics, efficacy data, and how to switch safely between formulations.
Diagnosis requires two morning total testosterone results below 300 ng/dL, confirmed symptoms, then LH and FSH to classify primary vs secondary hypogonadism.
Testosterone under 300 ng/dL overlaps with depression and anxiety symptoms; men with low T face 2-4x higher depression rates, per Endocrine Society criteria.
A detailed, guideline-based monitoring schedule for men on testosterone replacement therapy (TRT), covering baseline labs, 3-month check-ins, 6-month evaluations, and annual assessments per Endocrine Society and AUA recommendations.
A guide to the most common comorbidities linked to menopause, including cardiovascular disease, osteoporosis, type 2 diabetes, depression, and genitourinary syndrome, with evidence-based treatment approaches.
A clinical review of the most promising menopause research in 2024-2026, including NK3 receptor antagonists, estetrol, microbiome therapies, and updated guideline shifts.
A side-by-side comparison of major society guidelines for menopause diagnosis, hormone therapy, and long-term management from NAMS, the Endocrine Society, AACE, ADA, and USPSTF.
How your genes and family history influence weight gain during menopause, including key genetic variants, heritability estimates, and evidence-based strategies to manage hereditary risk.
A side-by-side comparison of major society guidelines on managing menopause-related weight gain, including pharmacotherapy thresholds, HRT recommendations, and lifestyle interventions from ADA, AACE, the Endocrine Society, NAMS, and USPSTF.
Explore the bidirectional relationship between menopause-related weight gain and mental health conditions including depression, anxiety, and emotional eating, with evidence-based treatment strategies.
Endocrine Society advises against testosterone therapy in untreated severe OSA. See this rule alongside ADA, AACE, AASM, and USPSTF guidance compared.
Evidence-based guide for caregivers and families supporting someone through perimenopause, covering communication strategies, treatment literacy, mental health support, and clinical resources.
A step-by-step perimenopause diagnostic algorithm covering STRAW+10 staging, lab workup, differential diagnosis, and treatment initiation based on major society guidelines.
A side-by-side comparison of major society guidelines for diagnosing and treating perimenopause, including hormone therapy recommendations from NAMS, the Endocrine Society, AACE, and USPSTF.
Estrogen fluctuations during perimenopause increase the risk of new-onset depression, anxiety, and brain fog. Learn how clinicians diagnose and treat the mental health overlap.
Evidence-based nutrition, exercise, and lifestyle strategies for managing perimenopause symptoms, backed by major society guidelines and clinical trial data.
Secondary hypogonadism frequently co-occurs with depression, anxiety, and cognitive decline. Learn how hypothalamic-pituitary dysfunction links low testosterone to mental health conditions, and what evidence-based treatments can help.
Evidence-based guide to testosterone cypionate's effect on apolipoprotein B (ApoB), including direction of change, magnitude, time course, mechanism, and monitoring recommendations.
Testosterone cypionate raises estradiol levels through aromatization. What is established, what is plausible but unproven, and how sensitive-assay monitoring should be timed and interpreted.
Testosterone cypionate lowers SHBG (sex hormone-binding globulin) by 10 to 30% within weeks of initiation. Learn the mechanism, clinical significance, monitoring schedule, and what declining SHBG means for free testosterone and estradiol.
Board-reviewed guide to the Adderall XR (mixed amphetamine salts) and testosterone interaction. Covers pharmacokinetic overlap, polycythemia risk, cardiovascular monitoring, and dose-adjustment considerations.
Clinical guide to combining alendronate (Fosamax) with testosterone replacement therapy. Covers pharmacokinetic and pharmacodynamic interactions, monitoring protocols, and safety data.
Clinical guide to combining alirocumab (Praluent) with testosterone replacement therapy. Covers mechanism, severity, lipid monitoring, dose adjustment, and patient counseling.
Clinical guide to the interaction between AndroGel (testosterone gel) and estradiol hormone replacement therapy, covering pharmacology, VTE risk, monitoring protocols, and dose adjustment.
Board-reviewed guide to combining AndroGel (testosterone gel) with progesterone hormone replacement therapy. Covers mechanism, severity, monitoring labs, dose adjustments, and patient counseling.
AndroGel is testosterone gel. Using it alongside other testosterone formulations creates additive androgen exposure, raising polycythemia and cardiovascular risk. Full clinical review with monitoring guidance.
Can you take Armour Thyroid with finasteride? A guide covering the pharmacokinetic and pharmacodynamic interaction profile, monitoring protocols, and dose-adjustment considerations.
Can you take Armour Thyroid with metformin? A guide covering the pharmacokinetic interaction, TSH monitoring changes, dose timing, and clinical safety data for combining natural desiccated thyroid with metformin.
Is it safe to take Armour Thyroid (natural desiccated thyroid) with sildenafil? A clinician-level review of pharmacokinetic and pharmacodynamic interactions, monitoring parameters, and dose-adjustment strategies.
Board-reviewed guide to combining Armour Thyroid (natural desiccated thyroid) with tadalafil (Cialis). Covers CYP metabolism, cardiovascular overlap, absorption timing, and monitoring.
Can you take Vyleesi (bremelanotide) with progesterone HRT? Review the pharmacodynamic interaction, sedation overlap, monitoring requirements, and dose-adjustment strategies.
Can you take Cialis with estradiol HRT? A clinician-grade review of the tadalafil-estradiol interaction covering CYP metabolism, cardiovascular overlap, VTE risk, monitoring, and dose adjustment.
Can you take CJC-1295 (modified GRF 1-29) with testosterone? A guide covering pharmacodynamic interactions, polycythemia risk, lipid overlap, monitoring protocols, and dose-adjustment strategies.
A source-audited guide to combining dutasteride (Avodart) with testosterone replacement therapy: what is established about the DHT-testosterone pharmacodynamic interaction, what monitoring is reasonable, and where the evidence needs verification.
Clinical guide to the pharmacodynamic interaction between enclomiphene citrate and estradiol hormone replacement therapy, including VTE risk, mechanism of antagonism, monitoring protocols, and dose adjustment.
Can you take enclomiphene citrate with testosterone? Learn the pharmacodynamic conflict, monitoring protocols, and evidence-based guidance for combining these therapies.
Can you take oral estradiol with metformin? A guide covering the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose-adjustment considerations.
Can you take an estradiol patch with finasteride? A guide covering pharmacokinetic and pharmacodynamic interactions, monitoring protocols, dose adjustments, and patient counseling.
Can you take Repatha (evolocumab) with testosterone? A guide to the pharmacodynamic interaction, lipid monitoring, polycythemia risk, and dose-adjustment considerations.
Can you take finasteride with progesterone HRT? A guide to the drug interaction, shared hormonal pathways, sedation overlap, monitoring protocols, and dose-adjustment strategies.
Can you take Leqvio with testosterone? A guide covering the pharmacokinetic and pharmacodynamic interaction between inclisiran and testosterone, including lipid effects, polycythemia risk, monitoring labs, and dose adjustment protocols.
Can you take Lantus with testosterone? Learn about the insulin glargine and testosterone interaction, including effects on blood glucose, polycythemia risk, monitoring protocols, and dose adjustments.
Can you take ipamorelin with testosterone? A guide covering pharmacodynamic overlap, polycythemia risk, lipid effects, monitoring protocols, and dose-adjustment strategies.
Jatenzo (oral testosterone undecanoate) combined with exogenous testosterone is therapeutic duplication. Learn the risks of polycythemia, lipid shifts, and cardiovascular events, plus monitoring protocols.
A clinical review of the lemborexant (Dayvigo) and testosterone interaction, covering CYP3A4 metabolism overlap, sleep apnea risk, monitoring considerations, and what remains unverified.
A clinical guide to the levothyroxine-testosterone interaction covering mechanism, severity, monitoring labs, dose adjustments, and patient counseling.
Clinical guide to combining Tirosint (levothyroxine liquid/gel cap) with testosterone therapy. Covers pharmacokinetic mechanisms, monitoring protocols, dose adjustments, and patient counseling.
Clinical review of the low-dose naltrexone (LDN) and estradiol HRT interaction, including pharmacokinetic mechanisms, safety data, monitoring recommendations, and dose-adjustment guidance.
Can you take low-dose naltrexone (LDN) with progesterone hormone replacement therapy? Review of pharmacokinetic overlap, sedation risk, CYP3A4 metabolism, monitoring recommendations, and clinical guidance.
Clinical review of the low-dose naltrexone (LDN) and testosterone interaction covering pharmacokinetics, pharmacodynamic overlap, liver safety, hematocrit monitoring, and dose-adjustment guidance.
Can you take metformin with progesterone HRT? A guide covering pharmacokinetic and pharmacodynamic interactions, monitoring protocols, dose adjustments, and patient counseling.
Can you take metformin with testosterone? A guide covering pharmacokinetic data, polycythemia risk, lipid effects, monitoring protocols, and dose-adjustment strategies.
Can you take Mounjaro (tirzepatide) with estradiol hormone replacement therapy? A clinician-grade review of absorption effects, VTE risk, monitoring, and dose-adjustment strategies.
Can Mounjaro (tirzepatide) be taken with progesterone HRT? A guide to the gastric-emptying mechanism, absorption timing, and monitoring questions clinicians and patients should ask, with clear notes on what is established versus not yet studied.
Can you take oral micronized progesterone (Prometrium) with finasteride? A guide covering pharmacokinetic and pharmacodynamic interactions, monitoring protocols, and dose-adjustment strategies.
Evidence-based review of the drug interaction between oral micronized progesterone (Prometrium) and metformin, covering CYP metabolism, clinical safety data, monitoring protocols, and dose-adjustment guidance.
Can you take oral micronized progesterone (Prometrium) with tadalafil (Cialis)? A guide covering CYP3A4 metabolism overlap, blood pressure effects, severity ratings, dose adjustment, and monitoring.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.